
HumaPen Savvio Insulin Pen
Reusable Peptide delivery device by Lilly
$52.00
Out of stock
The HumaPen Savvio is a reusable insulin delivery device (insulin pen) designed by Eli Lilly for precise subcutaneous administration of insulin from 3 ml Lilly cartridges (e.g., Humalog, Humulin, Basaglar). It’s a sleek, ergonomic pen with a dosing dial that delivers 1–60 units per injection in 1-unit increments. While primarily designed for insulin, it’s sometimes used off-label for peptides like Retatrutide in research settings due to its precision and compatibility with similar cartridge systems. It’s available in colors like red, graphite, blue, green, silver, and pink.Uses and BenefitsThe HumaPen Savvio is used for self-injection, primarily for diabetes management, but relevant for peptide administration in research contexts. Key benefits include:
Precision Dosing: Delivers accurate doses (1–60 units, adjustable in 1-unit increments), ideal for insulin or peptides requiring exact amounts (e.g., Retatrutide’s 1–12 mg/week).
Ease of Use: Features a smooth injection button, ergonomic grip, and clear dose window for straightforward operation.
Durability: Made of high-quality, scratch-resistant anodized aluminum, ensuring long-term reliability.
Portability: Compact and lightweight, resembling a stylish accessory, making it discreet and travel-friendly.
Reusability: Compatible with replaceable 3 ml Lilly cartridges, reducing waste compared to disposable pens.
Comfort: Smooth glide force and audible clicks confirm dosing, enhancing user confidence.
Trusted source for high-quality research peptides.
Support
info@peptidea.net
© 2025. All rights reserved.
Peptidea is a supplier of high-purity peptides, proteins, and amino acid derivatives intended solely for research and development purposes. Our products are not for human consumption. In research settings, peptides are often studied for their potential applications in areas such as weight management, anti-aging, and energy enhancement. All products are provided as lyophilized powders, requiring reconstitution with bacteriostatic water for research use. The statements on this website have not been evaluated by the US Food and Drug Administration, and our products are not intended to diagnose, treat, cure, or prevent any disease. Peptidea is a chemical supplier and is neither a compounding pharmacy nor a chemical compounding facility as defined under Section 503A of the Federal Food, Drug, and Cosmetic Act, nor an outsourcing facility as defined under Section 503B of the same Act.